Industry Press Releases

4th Annual Drug Discovery USA Congress

Thursday, Jun 15, 2017
Pressreleases

Oxford Global is proud to announce that early bird registration is open for the 4th Annual Drug Discovery USA Congress, 9-10 October 2017, San Diego. Across the two days 250+ senior level attendees will join us to hear 40+ presentations and case studies giving you the chance to explore the key areas shaping this exclusive field of key therapeutic areas of Immuno-therapy, Autoimmune Diseases, Neuroscience & Oncology.

View Agenda >>

4 interactive streams

•  Drug Discovery Innovation and Strategies, Enabling Technologies
•  Phenotypic Drug Discovery, High Throughput Technologies and RNAi Screening
•  Discovery Chemistry: Medicinal and Computational Chemistry
•  Discovery Chemistry: Novel Approaches to Drug Design

A truly unmissable congress; hear from internationally renowned senior experts in the cell & gene therapy field, including:

Strategic Use of Fluorine & Analysis of the Impact of Fluorine Substitution on P-Glycoprotein Mediated Efflux, Permeability, Lipophilicity & Metabolic Stability by Martin Pettersson, Medicinal Chemistry Team Leader, Pfizer

Chemistry & Chemical Biology Technologies for Improving Probability of Success by Anil Vasudevan, Director, Discovery Chemistry & Technology, AbbVie

A RNAi Therapeutic Approach for Cancer Treatment by Patrick Liu, Founder, President & CEO, Sirnaomics

Lung Specific Delivery Using Caveolae Associated Protein PV-1 Antibody Improves Drug Efficacy by Ping Tsui, Associate Director & Principal Scientist, Antibody Discovery & Protein Engineering, MedImmune

FREE LIVE WEBINAR & RECORDINGS

Innovative Computational Approaches to Drug Discovery Presented by Jonas Boström, Principal Scientist, AstraZeneca & Ron Alfa, Vice President Discovery, Recursion Pharma
Download for Free >>

Fragment-based Drug Discovery: from inception to drug Hosted by Vincent Stoll, Associate Director of Structural Biology, AbbVie.
Download for Free >>

Free access to our co-located Event
This congress also gives access to our co-located 2nd Biomarkers & Precision Medicine Congress and offers a shared networking environment for attendees to gain valuable insights into this advancing industry.

Notes to editors:
1. Guillaume Alonso, Marketing Executive. Phone +44(0) 1865 248455 e-mail g.alonso@oxfordglobal.co.uk
2. Oxford Global Conferences produce cutting edge congresses and summits for the Life Sciences Industry.
3. Oxford Global Conferences Ltd. Phone +44(0) 1865 248455, Fax +44(0) 1865 250985, e-mail: info@oxfordglobal.co.uk , Web: www.oxfordglobal.co.uk

Other Press Releases